Cargando…
Hepatocyte TRAF3 promotes insulin resistance and type 2 diabetes in mice with obesity
OBJECTIVE: Metabolic inflammation is believed to promote insulin resistance and type 2 diabetes progression in obesity. TRAF3, a cytoplasmic signaling protein, has been known to mediate/modulate cytokine signaling in immune cells. The goal is to define the metabolic function of hepatic TRAF3 in the...
Autores principales: | Chen, Zheng, Canet, Mark J., Sheng, Liang, Jiang, Lin, Xiong, Yi, Yin, Lei, Rui, Liangyou |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4731737/ https://www.ncbi.nlm.nih.gov/pubmed/26909311 http://dx.doi.org/10.1016/j.molmet.2015.09.013 |
Ejemplares similares
-
Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling
por: Wang, Pi-Xiao, et al.
Publicado: (2016) -
Hepatic TRAF2 Regulates Glucose Metabolism Through Enhancing Glucagon Responses
por: Chen, Zheng, et al.
Publicado: (2012) -
Hepatocyte Growth Factor Prevented High-Fat Diet-Induced Obesity and Improved Insulin Resistance in Mice
por: Muratsu, Jun, et al.
Publicado: (2017) -
Hepatocyte-Specific Phgdh-Deficient Mice Culminate in Mild Obesity, Insulin Resistance, and Enhanced Vulnerability to Protein Starvation
por: Hamano, Momoko, et al.
Publicado: (2021) -
Adipose METTL14‐Elicited N(6)‐Methyladenosine Promotes Obesity, Insulin Resistance, and NAFLD Through Suppressing β Adrenergic Signaling and Lipolysis
por: Kang, Qianqian, et al.
Publicado: (2023)